Alkermes (ALKS) Financials

$29.35 -0.70 (-2.33%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$29.35 0.00 (0.00%)

As of 05/23/2025 05:00 PM Eastern

Annual Income Statements for Alkermes

This table shows Alkermes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	368	364	-165	-51	-110	-195	-139	-158	-208	-227
Consolidated Net Income / (Loss)	367	356	-158	-48	-111	-197	-139	-158	-208	-227
Net Income / (Loss) Continuing Operations	372	519	-33	76	-111	-197	-139	-158	-208	-227
Total Pre-Tax Income	444	422	-31	88	-97	-197	-127	-143	-214	-224
Total Operating Income	421	414	-6.09	98	-112	-175	-99	-148	-209	-224
Total Gross Profit	1,312	1,410	894	976	860	991	918	749	614	489
Total Revenue	1,558	1,663	1,112	1,174	1,039	1,171	1,094	903	746	628
Operating Revenue	1,558	1,663	1,112	1,174	1,039	1,171	1,094	903	746	628
Total Cost of Revenue	245	253	218	197	178	180	176	155	132	139
Operating Cost of Revenue	245	253	218	197	178	180	176	155	132	139
Total Operating Expenses	892	996	900	879	973	1,166	1,017	897	822	714
Selling, General & Admin Expense	645	690	591	550	539	599	526	422	374	312
Research & Development Expense	245	271	273	291	395	513	425	413	387	344
Amortization Expense	1.10	36	36	38	39	40	65	62	61	58
Total Other Income / (Expense), net	23	7.40	-25	-10	16	-22	-28	4.63	-5.72	0.30
Interest Expense	23	23	13	11	8.66	14	15	12	15	13
Interest & Investment Income	42	31	7.63	2.41	6.96	14	9.24	4.65	3.75	3.33
Other Income / (Expense), net	3.24	-0.43	-20	-1.21	18	-22	-22	12	5.42	10
Income Tax Expense	72	-98	2.02	11	14	-0.44	12	15	-5.94	3.16
Net Income / (Loss) Discontinued Operations	-5.07	-163	-125	-125	-	-	-	-	-	-
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-1.14	-7.78	7.17	2.37	-0.47	-1.46	-0.51	0.52	-0.52	-
Basic Earnings per Share	$2.22	$2.14	($0.97)	($0.30)	($0.70)	($1.25)	($0.90)	($1.03)	($1.38)	($1.52)
Weighted Average Basic Shares Outstanding	165.39M	166.22M	163.74M	160.94M	158.80M	157.05M	155.11M	153.42M	151.48M	149.21M
Diluted Earnings per Share	$2.17	$2.10	($0.97)	($0.29)	($0.70)	($1.25)	($0.90)	($1.03)	($1.38)	($1.52)
Weighted Average Diluted Shares Outstanding	169.20M	169.73M	163.74M	164.75M	158.80M	157.05M	155.11M	153.42M	151.48M	149.21M
Weighted Average Basic & Diluted Shares Outstanding	162.61M	167.08M	164.39M	160.94M	158.80M	157.05M	155.11M	153.42M	151.48M	149.21M

This table shows Alkermes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	23	144	96	91	36	116	49	238	-39	-26	-66
Consolidated Net Income / (Loss)	22	147	92	91	37	113	48	237	-42	-28	-64
Net Income / (Loss) Continuing Operations	22	146	93	95	39	161	92	279	-12	97	-64
Total Pre-Tax Income	25	170	110	117	47	58	93	282	-11	114	-67
Total Operating Income	14	163	105	110	43	55	89	281	-11	116	-61
Total Gross Profit	257	368	315	338	292	307	319	554	229	251	202
Total Revenue	307	430	378	399	350	377	381	617	288	305	252
Operating Revenue	307	430	378	399	350	377	381	617	288	305	252
Total Cost of Revenue	49	62	63	61	59	70	61	63	58	54	51
Operating Cost of Revenue	49	62	63	61	59	70	61	63	58	54	51
Total Operating Expenses	244	205	210	228	248	253	230	273	240	135	262
Selling, General & Admin Expense	172	147	150	168	180	170	156	196	168	143	153
Research & Development Expense	72	58	60	60	68	74	65	68	64	-17	100
Amortization Expense	0.00	0.01	0.01	0.01	1.06	9.00	9.00	8.90	8.80	9.17	9.17
Total Other Income / (Expense), net	12	7.20	5.47	6.84	3.60	3.69	3.51	0.56	-0.36	-1.11	-6.73
Interest Expense	0.00	4.65	6.00	5.95	5.98	6.05	6.01	5.68	5.29	4.77	3.55
Interest & Investment Income	10	11	11	11	9.40	9.75	9.37	6.77	4.97	3.92	2.24
Other Income / (Expense), net	1.56	0.45	0.56	2.05	0.18	-0.01	0.15	-0.53	-0.04	-0.26	-5.41
Income Tax Expense	3.03	24	17	22	7.96	-102	1.15	2.73	0.72	18	-3.39
Net Income / (Loss) Discontinued Operations	0.00	0.77	-0.41	-3.30	-2.12	-48	-44	-42	-30	-	-
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-0.51	2.39	-4.02	-0.01	0.49	-2.96	-1.36	-0.69	-2.76	-1.95	2.35
Basic Earnings per Share	$0.14	$0.89	$0.57	$0.54	$0.22	$0.67	$0.29	$1.43	($0.25)	($0.18)	($0.39)
Weighted Average Basic Shares Outstanding	163.41M	165.39M	163.37M	168.32M	167.98M	166.22M	166.61M	166.28M	165.09M	163.74M	164.28M
Diluted Earnings per Share	$0.13	$0.88	$0.55	$0.53	$0.21	$0.69	$0.28	$1.38	($0.25)	($0.18)	($0.39)
Weighted Average Diluted Shares Outstanding	168.74M	169.20M	167.03M	170.98M	172.98M	169.73M	171.90M	171.55M	165.09M	163.74M	164.28M
Weighted Average Basic & Diluted Shares Outstanding	164.90M	162.61M	161.80M	164.67M	169.22M	167.08M	166.88M	166.56M	166.12M	164.39M	164.31M

This table details how cash moves in and out of Alkermes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-166	165	-45	65	69	-63	75	4.92	5.27	-43
Net Cash From Operating Activities	439	401	21	102	83	72	99	19	-64	-40
Net Cash From Continuing Operating Activities	439	401	21	102	83	72	99	19	-64	-40
Net Income / (Loss) Continuing Operations	367	356	-158	-48	-111	-197	-139	-158	-208	-227
Consolidated Net Income / (Loss)	367	356	-158	-48	-111	-197	-139	-158	-208	-227
Depreciation Expense	29	75	78	79	82	80	104	99	94	86
Non-Cash Adjustments To Reconcile Net Income	106	127	119	115	87	104	115	105	95	55
Changes in Operating Assets and Liabilities, net	-62	-156	-18	-43	25	85	20	-26	-45	47
Net Cash From Investing Activities	-111	53	-65	-66	-11	-142	-22	-18	127	-43
Net Cash From Continuing Investing Activities	-111	53	-65	-66	-11	-142	-22	-18	127	-43
Purchase of Property, Plant & Equipment	-33	-48	-38	-28	-42	-91	-69	-51	-44	-53
Purchase of Investments	-487	-254	-310	-340	-230	-278	-398	-432	-375	-509
Sale of Property, Plant & Equipment	0.46	0.35	0.00	0.29	0.64	0.90	0.51	0.16	0.19	0.54
Divestitures	98	0.00	0.00	-	-	-	-	-	-	50
Sale and/or Maturity of Investments	310	356	282	295	256	225	444	464	561	468
Other Investing Activities, net	0.04	0.00	1.76	6.94	3.89	10	0.00	0.00	-	-
Net Cash From Financing Activities	-494	-290	-1.57	29	-2.17	6.77	-1.62	4.08	-58	41
Net Cash From Continuing Financing Activities	-494	-290	-1.57	29	-2.17	6.77	-1.62	4.08	-58	41
Repayment of Debt	-292	-3.00	-3.00	-3.24	-2.84	-2.84	-2.88	-3.00	-69	-6.75
Repurchase of Common Equity	-200	0.00	0.00	-	-	-	-	-	-	-
Issuance of Common Equity	28	17	20	25	8.37	19	21	24	20	45
Other Financing Activities, net	-30	-303	-18	-17	-7.70	-9.32	-20	-16	-9.24	2.67
Cash Interest Paid	23	23	14	6.90	8.29	13	13	11	12	12
Cash Income Taxes Paid	2.59	44	21	1.89	0.62	2.51	0.75	2.99	5.53	0.71

This table details how cash moves in and out of Alkermes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	109	-105	-139	114	-37	-190	-18	344	29	29	9.31
Net Cash From Operating Activities	99	190	82	146	21	107	100	216	-21	1.05	0.63
Net Cash From Continuing Operating Activities	99	190	82	146	21	107	100	216	-21	1.05	0.63
Net Income / (Loss) Continuing Operations	22	147	92	91	37	113	48	237	-42	-28	-64
Consolidated Net Income / (Loss)	22	147	92	91	37	113	48	237	-42	-28	-64
Depreciation Expense	7.42	6.85	6.97	6.66	8.06	19	19	19	19	20	20
Non-Cash Adjustments To Reconcile Net Income	2.37	10	41	41	13	58	29	-14	54	46	42
Changes in Operating Assets and Liabilities, net	67	27	-58	6.84	-37	-82	4.24	-27	-52	-36	2.79
Net Cash From Investing Activities	9.10	-14	-109	52	-40	-21	-119	121	73	28	8.90
Net Cash From Continuing Investing Activities	9.10	-14	-109	52	-40	-21	-119	121	73	28	8.90
Purchase of Property, Plant & Equipment	-10	-9.77	-8.26	-7.11	-8.34	-17	-14	-9.71	-6.86	-10	-10
Purchase of Investments	-96	-90	-187	-95	-115	-68	-156	-6.39	-24	-53	-62
Sale of Property, Plant & Equipment	1.71	0.01	0.02	0.02	0.41	0.35	0.00	0.00	0.00	-	-
Sale and/or Maturity of Investments	113	86	86	56	82	64	51	137	104	91	81
Net Cash From Financing Activities	0.75	-282	-111	-83	-18	-276	1.57	7.84	-23	-0.27	-0.21
Net Cash From Continuing Financing Activities	0.75	-282	-111	-83	-18	-276	1.57	7.84	-23	-0.27	-0.21
Repayment of Debt	0.00	-290	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75
Issuance of Common Equity	30	8.22	5.52	2.61	11	1.65	3.11	9.13	2.87	0.78	0.86
Other Financing Activities, net	-29	-0.34	-0.29	-0.65	-28	-277	-0.80	-0.54	-25	-0.30	-0.32

This table presents Alkermes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	2,056	2,136	1,964	2,024	1,950	1,805	1,825	1,797	1,726	1,856
Total Current Assets	1,415	1,486	1,130	1,062	1,111	962	983	809	791	755
Cash & Equivalents	291	457	292	338	273	204	267	191	186	181
Short-Term Investments	461	316	316	199	362	331	273	242	311	354
Accounts Receivable	385	332	288	313	275	257	292	234	191	155
Inventories, net	183	186	181	150	126	102	90	93	63	38
Prepaid Expenses	91	98	41	49	61	60	53	48	39	26
Other Current Assets	4.99	95	8.93	13	25	8.39	8.23	0.00	-	-
Other Current Nonoperating Assets	0.00	0.00	2.32	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	228	227	223	341	350	362	310	285	265	255
Total Noncurrent Assets	413	424	611	621	479	481	532	704	671	846
Long-Term Investments	73	40	132	229	25	79	81	157	122	264
Goodwill	84	85	83	93	93	93	93	93	93	93
Noncurrent Deferred & Refundable Income Taxes	155	196	115	82	86	97	86	99	48	41
Other Noncurrent Operating Assets	101	103	206	143	163	62	81	99	90	69
Total Liabilities & Shareholders' Equity	2,056	2,136	1,964	2,024	1,950	1,805	1,825	1,797	1,726	1,856
Total Liabilities	591	934	920	912	883	720	654	594	517	541
Total Current Liabilities	465	520	498	471	438	391	340	291	212	236
Short-Term Debt	0.00	3.00	3.00	3.00	19	2.84	2.84	3.00	3.00	66
Accounts Payable	185	241	220	208	412	373	334	286	207	169
Accrued Expenses	272	264	252	237	-	-	-	-	-	-
Current Deferred Revenue	1.25	2.73	-	-	-	6.77	3.17	1.96	1.94	1.74
Other Current Liabilities	6.17	5.75	17	23	7.51	8.47	0.00	-	-	-
Other Current Nonoperating Liabilities	0.00	4.54	5.84	-	-	-	-	-	-	-
Total Noncurrent Liabilities	125	413	422	441	444	329	314	303	305	305
Long-Term Debt	0.00	288	290	293	272	274	276	278	281	284
Other Noncurrent Operating Liabilities	125	126	119	148	53	32	28	19	17	13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,465	1,203	1,044	1,113	1,067	1,085	1,171	1,203	1,209	1,314
Total Preferred & Common Equity	1,465	1,203	1,044	1,113	1,067	1,085	1,171	1,203	1,209	1,314
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,465	1,203	1,044	1,113	1,067	1,085	1,171	1,203	1,209	1,314
Common Stock	2,863	2,739	2,915	2,800	2,687	2,588	2,469	2,340	2,233	2,116
Retained Earnings	-976	-1,344	-1,699	-1,541	-1,493	-1,382	-1,185	-1,044	-948	-739
Treasury Stock	-419	-189	-161	-143	-126	-118	-109	-89	-73	-59
Accumulated Other Comprehensive Income / (Loss)	-1.97	-3.11	-11	-3.72	-1.35	-1.82	-3.28	-3.79	-3.27	-3.80

This table presents Alkermes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,082	2,155	2,207	2,124	2,279	2,187	1,923	1,942
Total Current Assets	1,479	1,564	1,542	1,469	1,465	1,397	1,110	1,054
Cash & Equivalents	400	396	535	421	648	666	321	264
Short-Term Investments	484	513	341	324	241	163	279	316
Accounts Receivable	319	367	366	316	338	334	269	257
Inventories, net	183	191	195	198	192	189	185	166
Prepaid Expenses	90	94	101	112	43	44	47	40
Other Current Assets	3.05	2.97	3.49	98	2.77	0.00	8.43	10
Plant, Property, & Equipment, net	234	225	223	225	328	324	321	326
Total Noncurrent Assets	369	366	442	430	487	466	492	562
Long-Term Investments	32	19	86	63	106	78	92	167
Goodwill	84	84	84	83	93	93	93	93
Noncurrent Deferred & Refundable Income Taxes	152	160	167	183	162	153	151	137
Other Noncurrent Operating Assets	101	103	104	101	114	122	126	118
Total Liabilities & Shareholders' Equity	2,082	2,155	2,207	2,124	2,279	2,187	1,923	1,942
Total Liabilities	570	863	923	869	924	907	917	899
Total Current Liabilities	444	454	516	459	503	487	493	470
Accounts Payable	186	160	240	206	243	243	190	211
Accrued Expenses	250	282	263	241	238	223	282	236
Current Deferred Revenue	1.61	2.34	3.31	3.34	-	-	-	-
Other Current Liabilities	6.29	6.15	6.01	5.91	18	18	17	20
Total Noncurrent Liabilities	127	409	407	410	421	420	424	429
Other Noncurrent Operating Liabilities	127	124	121	123	132	131	135	139
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,512	1,292	1,284	1,255	1,356	1,280	1,006	1,043
Total Preferred & Common Equity	1,512	1,292	1,284	1,255	1,356	1,280	1,006	1,043
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,512	1,292	1,284	1,255	1,356	1,280	1,006	1,043
Common Stock	2,915	2,834	2,806	2,783	3,005	2,978	2,940	2,887
Retained Earnings	-954	-1,123	-1,215	-1,307	-1,456	-1,504	-1,741	-1,671
Treasury Stock	-448	-419	-303	-218	-187	-186	-186	-161
Accumulated Other Comprehensive Income / (Loss)	-1.46	0.43	-3.59	-3.60	-6.07	-7.44	-8.13	-13

This table displays calculated financial ratios and metrics derived from Alkermes' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.36%	49.61%	-5.28%	13.00%	-11.29%	7.01%	21.13%	21.15%	18.68%	1.54%
EBITDA Growth	-7.41%	837.05%	-70.24%	1,449.28%	88.90%	-584.00%	54.25%	65.69%	15.17%	-234.52%
EBIT Growth	2.46%	1,708.65%	-126.64%	201.79%	51.96%	-63.48%	11.14%	33.13%	5.06%	-8,227.03%
NOPAT Growth	-30.84%	12,066.46%	-105.01%	208.17%	35.93%	-77.02%	32.98%	29.12%	6.97%	-157.39%
Net Income Growth	3.18%	324.78%	-228.57%	56.55%	43.62%	-41.14%	11.80%	24.23%	8.24%	-655.67%
EPS Growth	3.33%	316.49%	-234.48%	58.57%	44.00%	-38.89%	12.62%	25.36%	9.21%	-623.81%
Operating Cash Flow Growth	9.41%	1,807.21%	-79.31%	22.78%	14.94%	-27.40%	417.36%	130.08%	-58.08%	-462.33%
Free Cash Flow Firm Growth	-1.13%	546.49%	-76.08%	275.76%	-265.07%	-531.14%	94.79%	20.43%	-116.53%	-120.04%
Invested Capital Growth	-6.49%	18.80%	-10.33%	-21.37%	9.24%	-9.91%	-7.05%	2.24%	1.00%	-9.00%
Revenue Q/Q Growth	3.49%	4.58%	-1.75%	3.94%	-11.33%	9.03%	3.83%	7.35%	7.25%	-1.88%
EBITDA Q/Q Growth	27.23%	-11.24%	-22.73%	3,925.51%	-151.00%	-5.82%	-366.03%	47.21%	32.76%	-1,078.83%
EBIT Q/Q Growth	34.41%	-12.80%	-117.19%	231.37%	-67.63%	-0.53%	-13.24%	19.47%	19.82%	-113.91%
NOPAT Q/Q Growth	-3.12%	12.60%	-178.74%	294.89%	-22.69%	-6.01%	-6.23%	16.57%	17.26%	-29.70%
Net Income Q/Q Growth	10.12%	65.68%	-22.55%	47.46%	-50.68%	2.17%	0.05%	6.71%	18.79%	-78.49%
EPS Q/Q Growth	9.60%	70.73%	-25.97%	50.00%	-55.56%	3.85%	-1.12%	8.04%	18.34%	-78.82%
Operating Cash Flow Q/Q Growth	23.36%	35.98%	-58.75%	-26.31%	43.90%	-20.37%	32.95%	309.47%	49.18%	-304.00%
Free Cash Flow Firm Q/Q Growth	9.61%	2.67%	45.17%	182.44%	-65.13%	-3,341.67%	62.08%	20.00%	-8.42%	-46.52%
Invested Capital Q/Q Growth	-1.99%	5.10%	-2.27%	2.49%	7.16%	1.48%	-2.52%	-0.77%	0.38%	-4.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	84.25%	84.79%	80.39%	83.19%	82.83%	84.59%	83.88%	82.87%	82.28%	77.88%
EBITDA Margin	29.04%	29.37%	4.69%	14.93%	-1.25%	-9.99%	-1.56%	-4.14%	-14.62%	-20.45%
Operating Margin	27.00%	24.90%	-0.55%	8.33%	-10.82%	-14.99%	-9.06%	-16.37%	-27.98%	-35.70%
EBIT Margin	27.21%	24.87%	-2.31%	8.22%	-9.13%	-16.86%	-11.04%	-15.05%	-27.26%	-34.07%
Profit (Net Income) Margin	23.57%	21.39%	-14.24%	-4.10%	-10.67%	-16.79%	-12.73%	-17.48%	-27.95%	-36.15%
Tax Burden Percent	82.72%	84.40%	508.44%	-54.91%	114.84%	99.78%	109.72%	110.24%	97.23%	101.41%
Interest Burden Percent	104.69%	101.89%	121.04%	90.87%	101.79%	99.81%	105.13%	105.41%	105.48%	104.63%
Effective Tax Rate	16.14%	-23.16%	0.00%	12.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	53.26%	80.91%	-0.70%	11.66%	-10.05%	-15.56%	-8.05%	-11.71%	-16.80%	-17.29%
ROIC Less NNEP Spread (ROIC-NNEP)	51.12%	112.22%	32.16%	48.71%	0.91%	6.21%	13.46%	5.16%	-0.89%	-1.61%
Return on Net Nonoperating Assets (RNNOA)	-25.74%	-49.23%	-13.98%	-16.08%	-0.25%	-1.86%	-3.69%	-1.38%	0.28%	0.53%
Return on Equity (ROE)	27.52%	31.67%	-14.68%	-4.42%	-10.30%	-17.43%	-11.74%	-13.10%	-16.52%	-16.76%
Cash Return on Invested Capital (CROIC)	59.96%	63.72%	10.20%	35.59%	-18.88%	-5.13%	-0.74%	-13.93%	-17.79%	-7.87%
Operating Return on Assets (OROA)	20.22%	20.18%	-1.29%	4.86%	-5.05%	-10.88%	-6.67%	-7.71%	-11.35%	-11.34%
Return on Assets (ROA)	17.51%	17.35%	-7.94%	-2.42%	-5.90%	-10.83%	-7.69%	-8.96%	-11.64%	-12.04%
Return on Common Equity (ROCE)	27.52%	31.67%	-14.68%	-4.42%	-10.30%	-17.43%	-11.74%	-13.10%	-16.52%	-16.76%
Return on Equity Simple (ROE_SIMPLE)	25.06%	29.58%	-15.16%	-4.33%	-10.39%	-18.11%	-11.89%	-13.13%	-17.23%	-17.28%
Net Operating Profit after Tax (NOPAT)	353	510	-4.26	85	-79	-123	-69	-104	-146	-157
NOPAT Margin	22.65%	30.66%	-0.38%	7.25%	-7.58%	-10.49%	-6.34%	-11.46%	-19.59%	-24.99%
Net Nonoperating Expense Percent (NNEP)	2.13%	-31.31%	-32.86%	-37.05%	-10.96%	-21.77%	-21.51%	-16.88%	-15.90%	-15.68%
Return On Investment Capital (ROIC_SIMPLE)	24.08%	34.15%	-0.32%	6.04%	-5.33%	-9.01%	-4.78%	-6.98%	-9.78%	-9.43%
Cost of Revenue to Revenue	15.75%	15.21%	19.61%	16.81%	17.17%	15.41%	16.12%	17.13%	17.72%	22.12%
SG&A Expenses to Revenue	41.42%	41.47%	53.13%	46.83%	51.87%	51.19%	48.11%	46.67%	50.17%	49.58%
R&D to Revenue	15.75%	16.28%	24.53%	24.79%	37.99%	43.80%	38.88%	45.71%	51.92%	54.81%
Operating Expenses to Revenue	57.24%	59.89%	80.93%	74.86%	93.66%	99.58%	92.94%	99.24%	110.26%	113.58%
Earnings before Interest and Taxes (EBIT)	424	414	-26	97	-95	-197	-121	-136	-203	-214
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	452	489	52	175	-13	-117	-17	-37	-109	-128
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.18	3.85	3.82	3.14	2.77	2.75	3.64	6.50	6.49	8.43
Price to Tangible Book Value (P/TBV)	3.37	4.14	4.32	3.70	3.42	3.55	4.80	9.16	9.83	13.15
Price to Revenue (P/Rev)	2.99	2.78	3.59	2.98	2.84	2.55	3.90	8.66	10.53	17.62
Price to Earnings (P/E)	12.64	12.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.91%	7.85%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.98	6.00	6.15	4.71	3.31	3.54	4.72	8.41	8.60	12.28
Enterprise Value to Revenue (EV/Rev)	2.46	2.47	3.19	2.58	2.60	2.26	3.58	8.32	10.08	16.91
Enterprise Value to EBITDA (EV/EBITDA)	8.46	8.40	67.97	17.28	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	9.03	9.93	0.00	31.35	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	10.85	8.05	0.00	35.55	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.72	10.23	168.43	29.76	32.62	36.77	39.50	391.58	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	9.64	10.22	57.04	11.65	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.24	0.28	0.27	0.38	0.26	0.24	0.23	0.23	0.27
Long-Term Debt to Equity	0.00	0.24	0.28	0.26	0.37	0.25	0.24	0.23	0.23	0.22
Financial Leverage	-0.50	-0.44	-0.43	-0.33	-0.27	-0.30	-0.27	-0.27	-0.31	-0.33
Leverage Ratio	1.57	1.83	1.85	1.82	1.74	1.61	1.53	1.46	1.42	1.39
Compound Leverage Factor	1.65	1.86	2.24	1.66	1.78	1.61	1.60	1.54	1.50	1.46
Debt to Total Capital	0.00%	19.47%	21.93%	21.00%	27.77%	20.34%	19.25%	18.96%	19.00%	21.03%
Short-Term Debt to Total Capital	0.00%	0.20%	0.22%	0.21%	1.26%	0.21%	0.20%	0.20%	0.20%	3.95%
Long-Term Debt to Total Capital	0.00%	19.27%	21.71%	20.79%	26.51%	20.13%	19.06%	18.76%	18.80%	17.08%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	80.53%	78.07%	79.00%	72.23%	79.66%	80.75%	81.04%	81.00%	78.97%
Debt to EBITDA	0.00	0.60	5.62	1.69	-31.59	-2.37	-16.33	-7.53	-2.60	-2.72
Net Debt to EBITDA	0.00	-1.07	-8.57	-2.68	19.23	2.88	19.92	8.27	3.08	3.49
Long-Term Debt to EBITDA	0.00	0.59	5.57	1.67	-30.16	-2.34	-16.16	-7.45	-2.58	-2.21
Debt to NOPAT	0.00	0.57	-68.81	3.47	-5.21	-2.26	-4.03	-2.72	-1.94	-2.23
Net Debt to NOPAT	0.00	-1.02	104.83	-5.52	3.17	2.75	4.91	2.99	2.30	2.86
Long-Term Debt to NOPAT	0.00	0.56	-68.10	3.44	-4.98	-2.23	-3.98	-2.69	-1.92	-1.81
Altman Z-Score	6.06	4.05	2.30	2.32	1.72	2.09	3.81	7.68	8.79	12.01
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.04	2.86	2.27	2.25	2.54	2.46	2.89	2.78	3.73	3.20
Quick Ratio	2.44	2.13	1.80	1.80	2.08	2.03	2.45	2.29	3.25	2.92
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	397	402	62	260	-148	-40	-6.42	-123	-155	-71
Operating Cash Flow to CapEx	1,329.75%	841.52%	55.01%	366.77%	199.25%	80.05%	144.04%	37.53%	-146.80%	-77.11%
Free Cash Flow to Firm to Interest Expense	17.59	17.44	4.77	23.16	-17.07	-2.98	-0.42	-10.25	-10.39	-5.39
Operating Cash Flow to Interest Expense	19.45	17.43	1.61	9.07	9.57	5.30	6.43	1.60	-4.29	-3.05
Operating Cash Flow Less CapEx to Interest Expense	17.99	15.36	-1.32	6.59	4.77	-1.32	1.97	-2.66	-7.20	-7.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.81	0.56	0.59	0.55	0.65	0.60	0.51	0.42	0.33
Accounts Receivable Turnover	4.34	5.36	3.70	3.99	3.90	4.26	4.16	4.25	4.30	4.09
Inventory Turnover	1.33	1.38	1.31	1.43	1.57	1.88	1.92	1.98	2.61	3.10
Fixed Asset Turnover	6.85	7.40	3.94	3.40	2.92	3.48	3.68	3.29	2.87	2.41
Accounts Payable Turnover	1.15	1.10	1.02	0.64	0.45	0.51	0.57	0.63	0.70	0.96
Days Sales Outstanding (DSO)	84.01	68.07	98.68	91.48	93.51	85.61	87.69	85.80	84.82	89.18
Days Inventory Outstanding (DIO)	274.71	265.29	277.64	255.33	232.88	194.25	189.79	184.30	140.08	117.87
Days Payable Outstanding (DPO)	316.82	332.24	358.68	574.04	803.63	715.09	641.29	581.67	519.08	380.78
Cash Conversion Cycle (CCC)	41.90	1.12	17.65	-227.23	-477.24	-435.22	-363.81	-311.58	-294.18	-173.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	640	685	576	643	817	748	831	894	874	865
Invested Capital Turnover	2.35	2.64	1.82	1.61	1.33	1.48	1.27	1.02	0.86	0.69
Increase / (Decrease) in Invested Capital	-44	108	-66	-175	69	-82	-63	20	8.61	-86
Enterprise Value (EV)	3,829	4,107	3,544	3,027	2,702	2,650	3,922	7,514	7,516	10,624
Market Capitalization	4,653	4,629	3,991	3,497	2,952	2,987	4,263	7,824	7,852	11,073
Book Value per Share	$9.05	$7.21	$6.35	$6.88	$6.70	$6.89	$7.54	$7.82	$7.96	$8.76
Tangible Book Value per Share	$8.54	$6.70	$5.62	$5.85	$5.42	$5.34	$5.71	$5.55	$5.25	$5.61
Total Capital	1,465	1,493	1,337	1,408	1,477	1,363	1,451	1,484	1,493	1,664
Total Debt	0.00	291	293	296	410	277	279	281	284	350
Total Long-Term Debt	0.00	288	290	293	392	274	276	278	281	284
Net Debt	-825	-523	-447	-470	-250	-337	-341	-309	-335	-449
Capital Expenditures (CapEx)	33	48	38	28	42	90	69	51	43	52
Debt-free, Cash-free Net Working Capital (DFCFNWC)	198	195	27	58	56	39	107	87	84	50
Debt-free Net Working Capital (DFNWC)	950	968	636	594	691	574	646	521	582	584
Net Working Capital (NWC)	950	965	633	591	673	571	643	518	579	519
Net Nonoperating Expense (NNE)	-14	154	154	133	32	74	70	54	62	70
Net Nonoperating Obligations (NNO)	-825	-518	-468	-470	-250	-337	-341	-309	-335	-449
Total Depreciation and Amortization (D&A)	29	75	78	79	82	80	104	99	94	86
Debt-free, Cash-free Net Working Capital to Revenue	12.74%	11.71%	2.44%	4.91%	5.42%	3.31%	9.78%	9.65%	11.33%	7.91%
Debt-free Net Working Capital to Revenue	61.00%	58.21%	57.17%	50.60%	66.55%	48.99%	59.06%	57.64%	78.01%	93.02%
Net Working Capital to Revenue	61.00%	58.03%	56.90%	50.34%	64.76%	48.75%	58.80%	57.31%	77.60%	82.56%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.22	$2.14	($0.97)	($0.30)	($0.70)	($1.25)	($0.90)	($1.03)	($1.38)	($1.52)
Adjusted Weighted Average Basic Shares Outstanding	165.39M	166.22M	163.54M	161.97M	159.24M	157.79M	156.04M	156.14M	152.55M	149.21M
Adjusted Diluted Earnings per Share	$2.17	$2.10	($0.97)	($0.30)	($0.70)	($1.25)	($0.90)	($1.03)	($1.38)	($1.52)
Adjusted Weighted Average Diluted Shares Outstanding	169.20M	169.73M	163.54M	161.97M	159.24M	157.79M	156.04M	156.14M	152.55M	149.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.30)	($0.70)	($1.25)	($0.90)	($1.03)	($1.38)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	162.61M	167.08M	164.39M	160.94M	158.80M	157.05M	155.11M	153.42M	151.48M	150.74M
Normalized Net Operating Profit after Tax (NOPAT)	353	290	-4.26	85	-79	-113	-69	-104	-146	-157
Normalized NOPAT Margin	22.65%	17.43%	-0.38%	7.25%	-7.58%	-9.69%	-6.34%	-11.46%	-19.59%	-24.99%
Pre Tax Income Margin	28.49%	25.34%	-2.80%	7.47%	-9.29%	-16.83%	-11.60%	-15.86%	-28.75%	-35.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	18.77	17.96	-1.97	8.60	-10.95	-14.52	-7.82	-11.32	-13.65	-16.16
NOPAT to Interest Expense	15.62	22.15	-0.33	7.59	-9.09	-9.03	-4.50	-8.62	-9.81	-11.85
EBIT Less CapEx to Interest Expense	17.31	15.89	-4.91	6.13	-15.75	-21.14	-12.29	-15.58	-16.57	-20.11
NOPAT Less CapEx to Interest Expense	14.16	20.07	-3.26	5.12	-13.89	-15.65	-8.96	-12.88	-12.73	-15.80
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	54.56%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Alkermes' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-12.52%	13.91%	-0.73%	-35.35%	21.83%	23.89%	50.95%	123.52%	3.25%	-6.10%	-14.21%
EBITDA Growth	-55.83%	132.34%	3.96%	-60.44%	569.18%	-45.81%	332.48%	2,520.11%	132.06%	-10.20%	-797.74%
EBIT Growth	-64.71%	198.67%	17.88%	-60.13%	494.98%	-52.64%	235.26%	983.48%	74.52%	-10.74%	-168.89%
NOPAT Growth	-66.19%	-7.21%	0.12%	-68.01%	568.16%	53.80%	307.51%	1,254.84%	58.73%	-23.34%	-208.46%
Net Income Growth	-39.00%	29.90%	93.44%	-61.46%	188.01%	499.16%	174.65%	886.65%	-16.55%	-3,336.43%	-120.69%
EPS Growth	-38.10%	27.54%	96.43%	-61.59%	184.00%	483.33%	171.79%	866.67%	-13.64%	-1,000.00%	-116.67%
Operating Cash Flow Growth	368.12%	77.55%	-18.17%	-32.30%	199.09%	10,142.31%	15,853.28%	9,454.29%	-198.27%	-96.62%	-99.25%
Free Cash Flow Firm Growth	261.22%	337.28%	227.75%	-37.68%	-6,322.67%	-74.38%	621.28%	172.10%	-101.63%	-45.68%	-104.15%
Invested Capital Growth	-19.22%	-6.49%	0.27%	-8.16%	21.69%	18.80%	10.47%	7.84%	-1.01%	-10.33%	-5.96%
Revenue Q/Q Growth	-28.72%	13.71%	-5.26%	13.92%	-7.18%	-0.91%	-38.30%	114.68%	-5.61%	20.73%	-8.64%
EBITDA Q/Q Growth	-86.61%	51.38%	-5.32%	130.07%	-29.54%	-32.26%	-63.97%	3,791.41%	-94.29%	390.61%	-275.08%
EBIT Q/Q Growth	-90.59%	54.91%	-5.92%	157.38%	-20.38%	-38.86%	-68.18%	2,649.67%	-109.55%	274.61%	-107.87%
NOPAT Q/Q Growth	-91.29%	58.25%	-1.04%	147.84%	-76.09%	70.75%	-68.38%	3,726.72%	-107.85%	330.39%	-75.99%
Net Income Q/Q Growth	-84.67%	58.59%	1.12%	148.07%	-67.35%	136.15%	-79.85%	666.53%	-48.10%	55.84%	-112.28%
EPS Q/Q Growth	-85.23%	60.00%	3.77%	152.38%	-69.57%	146.43%	-79.71%	652.00%	-38.89%	53.85%	-116.67%
Operating Cash Flow Q/Q Growth	-48.10%	133.36%	-44.13%	591.82%	-80.32%	7.55%	-53.78%	1,112.63%	-2,134.58%	67.52%	127.10%
Free Cash Flow Firm Q/Q Growth	-16.40%	112.91%	-39.76%	250.34%	-326.75%	59.58%	-88.55%	15,595.38%	-100.90%	3,346.47%	-105.98%
Invested Capital Q/Q Growth	-7.00%	-1.99%	6.91%	-17.11%	7.66%	5.10%	-2.09%	9.84%	5.11%	-2.27%	-4.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	83.95%	85.55%	83.31%	84.60%	83.26%	81.42%	83.86%	89.76%	79.78%	82.30%	79.94%
EBITDA Margin	7.43%	39.53%	29.69%	29.71%	14.71%	19.38%	28.35%	48.55%	2.68%	44.31%	-18.41%
Operating Margin	4.50%	37.84%	27.70%	27.53%	12.36%	14.47%	23.41%	45.56%	-3.82%	37.94%	-24.03%
EBIT Margin	5.01%	37.94%	27.85%	28.04%	12.41%	14.47%	23.45%	45.47%	-3.83%	37.86%	-26.18%
Profit (Net Income) Margin	7.33%	34.07%	24.43%	22.89%	10.51%	29.88%	12.54%	38.40%	-14.55%	-9.27%	-25.35%
Tax Burden Percent	88.13%	86.23%	83.81%	78.27%	78.50%	193.39%	51.52%	84.12%	369.23%	-24.68%	94.96%
Interest Burden Percent	166.07%	104.14%	104.67%	104.27%	107.87%	106.76%	103.77%	100.39%	102.92%	99.26%	101.99%
Effective Tax Rate	11.87%	14.22%	15.82%	18.90%	16.98%	-175.31%	1.24%	0.97%	0.00%	15.40%	0.00%
Return on Invested Capital (ROIC)	9.01%	76.33%	53.81%	52.76%	26.39%	105.14%	59.27%	102.89%	-4.92%	58.56%	-31.29%
ROIC Less NNEP Spread (ROIC-NNEP)	7.57%	75.29%	53.19%	52.41%	26.20%	112.77%	66.24%	110.57%	3.00%	85.45%	-26.62%
Return on Net Nonoperating Assets (RNNOA)	-3.93%	-37.90%	-26.98%	-26.33%	-10.64%	-49.48%	-31.97%	-50.57%	-1.24%	-37.15%	11.48%
Return on Equity (ROE)	5.09%	38.42%	26.83%	26.43%	15.75%	55.66%	27.31%	52.32%	-6.16%	21.41%	-19.81%
Cash Return on Invested Capital (CROIC)	70.70%	59.96%	55.55%	65.57%	63.35%	63.72%	63.06%	40.37%	-4.72%	10.20%	7.04%
Operating Return on Assets (OROA)	3.60%	28.20%	18.91%	19.25%	10.59%	11.74%	17.68%	32.08%	-2.20%	21.10%	-15.05%
Return on Assets (ROA)	5.28%	25.32%	16.58%	15.71%	8.97%	24.24%	9.45%	27.09%	-8.36%	-5.17%	-14.57%
Return on Common Equity (ROCE)	5.09%	38.42%	26.83%	26.43%	15.75%	55.66%	27.31%	52.32%	-6.16%	21.41%	-19.81%
Return on Equity Simple (ROE_SIMPLE)	23.33%	0.00%	25.80%	22.49%	34.62%	0.00%	15.84%	8.04%	-16.33%	0.00%	-12.38%
Net Operating Profit after Tax (NOPAT)	12	140	88	89	36	150	88	279	-7.68	98	-42
NOPAT Margin	3.97%	32.46%	23.32%	22.33%	10.26%	39.85%	23.12%	45.12%	-2.67%	32.10%	-16.82%
Net Nonoperating Expense Percent (NNEP)	1.44%	1.03%	0.62%	0.35%	0.19%	-7.64%	-6.97%	-7.68%	-7.91%	-26.89%	-4.67%
Return On Investment Capital (ROIC_SIMPLE)	0.80%	9.53%	5.58%	5.66%	2.33%	10.07%	5.35%	17.71%	-0.59%	7.31%	-3.18%
Cost of Revenue to Revenue	16.05%	14.45%	16.69%	15.40%	16.74%	18.58%	16.14%	10.24%	20.22%	17.70%	20.06%
SG&A Expenses to Revenue	56.02%	34.19%	39.77%	42.12%	51.30%	44.98%	41.05%	31.71%	58.36%	46.79%	60.54%
R&D to Revenue	23.43%	13.53%	15.84%	14.94%	19.30%	19.59%	17.03%	11.05%	22.17%	-5.43%	39.80%
Operating Expenses to Revenue	79.45%	47.72%	55.61%	57.07%	70.90%	66.95%	60.44%	44.20%	83.59%	44.36%	103.97%
Earnings before Interest and Taxes (EBIT)	15	163	105	112	43	55	89	281	-11	115	-66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	23	170	112	119	52	73	108	300	7.70	135	-46
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.55	3.18	3.57	3.18	3.60	3.85	3.20	3.78	4.28	3.82	3.27
Price to Tangible Book Value (P/TBV)	3.76	3.37	3.81	3.40	3.86	4.14	3.46	4.14	4.87	4.32	3.78
Price to Revenue (P/Rev)	3.55	2.99	3.06	2.70	2.62	2.78	2.73	3.31	3.84	3.59	3.01
Price to Earnings (P/E)	15.13	12.64	13.56	13.94	10.29	12.73	19.58	45.58	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.61%	7.91%	7.37%	7.17%	9.72%	7.85%	5.11%	2.19%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	7.48	5.98	6.08	5.57	5.43	6.00	5.58	6.34	6.45	6.15	5.01
Enterprise Value to Revenue (EV/Rev)	2.94	2.46	2.64	2.26	2.32	2.47	2.28	2.89	3.49	3.19	2.61
Enterprise Value to EBITDA (EV/EBITDA)	10.51	8.46	11.16	9.69	7.51	8.40	6.60	10.65	46.60	67.97	43.81
Enterprise Value to EBIT (EV/EBIT)	11.25	9.03	12.59	11.37	8.54	9.93	7.66	13.22	601.88	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	13.52	10.85	10.90	9.35	7.19	8.05	8.02	13.73	0.00	0.00	546.16
Enterprise Value to Operating Cash Flow (EV/OCF)	8.62	8.72	11.15	9.10	9.01	10.23	12.31	21.51	0.00	168.43	57.95
Enterprise Value to Free Cash Flow (EV/FCFF)	9.45	9.64	10.96	8.14	9.40	10.22	9.28	16.30	0.00	57.04	69.07
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.22	0.23	0.23	0.24	0.21	0.23	0.29	0.28	0.28
Long-Term Debt to Equity	0.00	0.00	0.22	0.22	0.23	0.24	0.21	0.23	0.29	0.28	0.28
Financial Leverage	-0.52	-0.50	-0.51	-0.50	-0.41	-0.44	-0.48	-0.46	-0.41	-0.43	-0.43
Leverage Ratio	1.52	1.57	1.67	1.71	1.79	1.83	1.76	1.75	1.87	1.85	1.84
Compound Leverage Factor	2.52	1.64	1.75	1.79	1.93	1.95	1.83	1.76	1.93	1.84	1.88
Debt to Total Capital	0.00%	0.00%	18.27%	18.40%	18.78%	19.47%	17.69%	18.57%	22.54%	21.93%	21.99%
Short-Term Debt to Total Capital	0.00%	0.00%	0.19%	0.19%	0.19%	0.20%	0.18%	0.19%	0.23%	0.22%	0.22%
Long-Term Debt to Total Capital	0.00%	0.00%	18.08%	18.21%	18.58%	19.27%	17.51%	18.38%	22.31%	21.71%	21.76%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	81.73%	81.60%	81.22%	80.53%	82.31%	81.43%	77.46%	78.07%	78.01%
Debt to EBITDA	0.00	0.00	0.81	0.82	0.54	0.60	0.53	0.74	3.49	5.62	4.36
Net Debt to EBITDA	0.00	0.00	-1.80	-1.92	-0.97	-1.07	-1.28	-1.55	-4.77	-8.57	-6.72
Long-Term Debt to EBITDA	0.00	0.00	0.80	0.82	0.54	0.59	0.52	0.73	3.45	5.57	4.31
Debt to NOPAT	0.00	0.00	0.79	0.80	0.52	0.57	0.64	0.95	-8.38	-68.81	54.30
Net Debt to NOPAT	0.00	0.00	-1.75	-1.85	-0.93	-1.02	-1.55	-2.00	11.46	104.83	-83.72
Long-Term Debt to NOPAT	0.00	0.00	0.79	0.79	0.52	0.56	0.64	0.94	-8.30	-68.10	53.74
Altman Z-Score	6.35	5.64	3.95	3.29	3.71	3.50	3.26	3.83	2.50	2.54	1.90
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.33	3.04	3.45	2.99	3.20	2.86	2.91	2.87	2.25	2.27	2.24
Quick Ratio	2.71	2.44	2.81	2.41	2.31	2.13	2.44	2.39	1.76	1.80	1.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	154	184	86	143	-95	42	26	230	-1.49	164	-5.06
Operating Cash Flow to CapEx	1,176.74%	1,949.59%	990.40%	2,060.24%	266.15%	642.83%	690.02%	2,223.36%	-310.52%	10.44%	5.97%
Free Cash Flow to Firm to Interest Expense	0.00	39.58	14.40	24.10	-15.96	6.95	4.39	40.49	-0.28	34.43	-1.42
Operating Cash Flow to Interest Expense	0.00	40.96	13.60	24.53	3.53	17.71	16.60	37.95	-4.03	0.22	0.18
Operating Cash Flow Less CapEx to Interest Expense	0.00	38.86	12.23	23.34	2.20	14.96	14.20	36.24	-5.33	-1.88	-2.77
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.72	0.74	0.68	0.69	0.85	0.81	0.75	0.71	0.57	0.56	0.57
Accounts Receivable Turnover	4.77	4.34	4.27	4.30	5.90	5.36	5.35	5.04	4.32	3.70	4.14
Inventory Turnover	1.24	1.33	1.32	1.31	1.32	1.38	1.32	1.31	1.30	1.31	1.43
Fixed Asset Turnover	6.60	6.85	5.44	5.52	6.33	7.40	4.87	4.42	3.41	3.94	3.39
Accounts Payable Turnover	1.20	1.15	1.26	1.04	1.28	1.10	1.04	1.05	1.22	1.02	0.68
Days Sales Outstanding (DSO)	76.50	84.01	85.47	84.83	61.85	68.07	68.25	72.44	84.53	98.68	88.11
Days Inventory Outstanding (DIO)	295.40	274.71	276.10	278.46	275.97	265.29	276.24	278.63	280.49	277.64	255.60
Days Payable Outstanding (DPO)	303.20	316.82	290.64	349.93	285.07	332.24	350.18	347.08	299.89	358.68	535.70
Cash Conversion Cycle (CCC)	68.70	41.90	70.93	13.35	52.75	1.12	-5.69	3.98	65.12	17.65	-191.99
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	595	640	653	611	737	685	651	665	606	576	590
Invested Capital Turnover	2.27	2.35	2.31	2.36	2.57	2.64	2.56	2.28	1.84	1.82	1.86
Increase / (Decrease) in Invested Capital	-142	-44	1.78	-54	131	108	62	48	-6.20	-66	-37
Enterprise Value (EV)	4,453	3,829	3,970	3,405	4,000	4,107	3,633	4,218	3,908	3,544	2,956
Market Capitalization	5,370	4,653	4,609	4,078	4,517	4,629	4,337	4,834	4,308	3,991	3,410
Book Value per Share	$9.30	$9.05	$7.85	$7.59	$7.47	$7.21	$8.14	$7.70	$6.12	$6.35	$6.35
Tangible Book Value per Share	$8.78	$8.54	$7.34	$7.09	$6.97	$6.70	$7.52	$7.02	$5.38	$5.62	$5.50
Total Capital	1,512	1,465	1,581	1,573	1,545	1,493	1,647	1,572	1,298	1,337	1,337
Total Debt	0.00	0.00	289	289	290	291	291	292	293	293	294
Total Long-Term Debt	0.00	0.00	286	286	287	288	288	289	290	290	291
Net Debt	-916	-825	-639	-673	-518	-523	-704	-615	-400	-447	-453
Capital Expenditures (CapEx)	8.40	9.77	8.24	7.09	7.93	17	14	9.70	6.86	10	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	151	198	205	154	268	195	76	84	20	27	7.06
Debt-free Net Working Capital (DFNWC)	1,035	950	1,113	1,030	1,013	968	965	913	620	636	587
Net Working Capital (NWC)	1,035	950	1,110	1,027	1,010	965	962	910	617	633	584
Net Nonoperating Expense (NNE)	-10	-6.94	-4.19	-2.24	-0.87	38	40	41	34	126	22
Net Nonoperating Obligations (NNO)	-916	-825	-639	-673	-518	-518	-704	-615	-400	-468	-453
Total Depreciation and Amortization (D&A)	7.42	6.85	6.97	6.66	8.06	19	19	19	19	20	20
Debt-free, Cash-free Net Working Capital to Revenue	10.00%	12.74%	13.59%	10.18%	15.51%	11.71%	4.75%	5.75%	1.76%	2.44%	0.62%
Debt-free Net Working Capital to Revenue	68.39%	61.00%	73.98%	68.28%	58.68%	58.21%	60.65%	62.46%	55.33%	57.17%	51.90%
Net Working Capital to Revenue	68.39%	61.00%	73.78%	68.08%	58.50%	58.03%	60.46%	62.25%	55.06%	56.90%	51.63%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	$0.89	$0.57	$0.54	$0.22	$0.67	$0.29	$1.43	($0.25)	($0.18)	($0.39)
Adjusted Weighted Average Basic Shares Outstanding	163.41M	165.39M	163.37M	168.32M	167.98M	166.22M	166.61M	166.28M	165.09M	163.74M	164.28M
Adjusted Diluted Earnings per Share	$0.13	$0.88	$0.55	$0.53	$0.21	$0.69	$0.28	$1.38	($0.25)	($0.18)	($0.39)
Adjusted Weighted Average Diluted Shares Outstanding	168.74M	169.20M	167.03M	170.98M	172.98M	169.73M	171.90M	171.55M	165.09M	163.74M	164.28M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	164.90M	162.61M	161.80M	164.67M	169.22M	167.08M	166.88M	166.56M	166.12M	164.39M	164.31M
Normalized Net Operating Profit after Tax (NOPAT)	12	140	88	89	36	38	88	279	-7.68	98	-42
Normalized NOPAT Margin	3.97%	32.46%	23.32%	22.33%	10.26%	10.13%	23.12%	45.12%	-2.67%	32.10%	-16.82%
Pre Tax Income Margin	8.32%	39.51%	29.15%	29.24%	13.39%	15.45%	24.34%	45.65%	-3.94%	37.58%	-26.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	35.10	17.55	18.81	7.28	9.02	14.88	49.39	-2.08	24.18	-18.60
NOPAT to Interest Expense	0.00	30.03	14.70	14.97	6.01	24.84	14.67	49.01	-1.45	20.51	-11.95
EBIT Less CapEx to Interest Expense	0.00	33.00	16.18	17.62	5.95	6.27	12.47	47.69	-3.38	22.08	-21.55
NOPAT Less CapEx to Interest Expense	0.00	27.92	13.32	13.78	4.69	22.09	12.26	47.30	-2.75	18.40	-14.90
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	54.56%	60.08%	29.33%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Alkermes' Financials

When does Alkermes's financial year end?

According to the most recent income statement we have on file, Alkermes' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Alkermes' net income changed over the last 9 years?

Alkermes' net income appears to be on a downward trend, with a most recent value of $367.07 million in 2024, falling from -$227.16 million in 2015. The previous period was $355.76 million in 2023. Find out what analysts predict for Alkermes in the coming months.

What is Alkermes's operating income?

Alkermes's total operating income in 2024 was $420.64 million, based on the following breakdown:

Total Gross Profit: $1.31 billion
Total Operating Expenses: $891.67 million

How has Alkermes revenue changed over the last 9 years?

Over the last 9 years, Alkermes' total revenue changed from $628.34 million in 2015 to $1.56 billion in 2024, a change of 147.9%.

How much debt does Alkermes have?

Alkermes' total liabilities were at $590.59 million at the end of 2024, a 36.7% decrease from 2023, and a 9.1% increase since 2015.

How much cash does Alkermes have?

In the past 9 years, Alkermes' cash and equivalents has ranged from $181.11 million in 2015 to $457.47 million in 2023, and is currently $291.15 million as of their latest financial filing in 2024.

How has Alkermes' book value per share changed over the last 9 years?

Over the last 9 years, Alkermes' book value per share changed from 8.76 in 2015 to 9.05 in 2024, a change of 3.4%.

Related Companies

This page (NASDAQ:ALKS) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alkermes (ALKS) Financials

Frequently Asked Questions About Alkermes' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alkermes (ALKS) Financials

Annual Income Statements for Alkermes

Quarterly Income Statements for Alkermes

Annual Cash Flow Statements for Alkermes

Quarterly Cash Flow Statements for Alkermes

Annual Balance Sheets for Alkermes

Quarterly Balance Sheets for Alkermes

Annual Metrics And Ratios for Alkermes

Quarterly Metrics And Ratios for Alkermes

Frequently Asked Questions About Alkermes' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools